Shares of Omada Health Inc (OMDA) have recently surpassed the average analyst 12-month target price of $23.33, trading at $23.50 per share. This movement triggers potential analyst responses, including downgrading valuations or adjusting target prices higher based on the company’s performance indicators.
There are currently 12 analysts covering Omada Health with varying target prices, with one as low as $15.00 and another as high as $30.00, leading to a standard deviation of $4.539. Presently, analysts maintain a positive outlook, with 8 strong buy ratings, 2 buy ratings, and 3 hold ratings, while no analysts have issued sell or strong sell ratings.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
